http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#head http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#assertion http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#assertion http://bio2rdf.org/drugbank:DB00541 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB01319 http://bio2rdf.org/drugbank:DB01319 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB01319 http://bio2rdf.org/drugbank_resource:DB00541_DB01319 http://purl.org/dc/terms/identifier drugbank_resource:DB00541_DB01319 http://bio2rdf.org/drugbank_resource:DB00541_DB01319 http://purl.org/dc/terms/title DDI between Vincristine and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Fosamprenavir is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00541_DB01319 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00541_DB01319 http://www.w3.org/2000/01/rdf-schema#label DDI between Vincristine and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Fosamprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB01319] http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#signature.MCwCFDF2S_5jQ83I http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#signature.MCwCFDF2S_5jQ83I http://purl.org/nanopub/x/hasSignature MCwCFDF2S/5jQ83IYOmasxNbP95lkSYRAhQKpbVnZFt89HKm178bFy7uONvVyA== http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#signature.MCwCFDF2S_5jQ83I http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://purl.org/dc/terms/created 2018-03-30T11:12:50.966+02:00 http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc#signature.MCwCFDF2S_5jQ83I http://bio2rdf.org/drugbank_resource:DB00541_DB01319_nanopub.RAn-myhknYV-ncpPuW3WYCDIMAEjSZyPWTwEgqryeVoDc http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234